investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide

Dennis Klinman

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

No posts

Related projects

John Koren

Novel Combination Therapeutic Strategies to Ablate Resistance to Hsp90 Inhibitors

All cancers but non-melanoma skin cancer

Peter Kent Jackson

Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer

Trachea, bronchus and lung

Ethan Dmitrovsky

Targeting Anaphase Catastrophe to Combat Lung Cancer

Trachea, bronchus and lung

Richard Paul Hershberger

Roswell Park Summer Internship Programs in Cancer Sciences and Oncology

All cancers but non-melanoma skin cancer

Marc Nicklaus

Synthetically Accessible Virtual Inventory (SAVI)

All cancers but non-melanoma skin cancer

Benjamin Raphael

Computational Characterization of Genetic Heterogeneity

All cancers but non-melanoma skin cancer

Kathleen Collins

Structure and Function of Telomerase

All cancers but non-melanoma skin cancer

Alexander D Sorkin

Pathogenesis of Cancer: Role of EGF Receptor Endocytosis

Trachea, bronchus and lung

Pathology

Katsonuri Sugimoto

Surveillance and Maintenance of DNA Ends

All cancers but non-melanoma skin cancer